Sam Brusco, Associate Editor11.28.23
GE HealthCare revealed an industry-first U.S. Food and Drug Administration (FDA) 510(k) clearance, its Critical Care Suite 2.1 featuring a pneumothorax (PTX) algorithm to detect, notify, triage, and diagnose PTX.
The updated PTX algorithm offers immediate notification of presence or absence of pneumothorax, as well as an overlay display both on the device and in PACS to help with PTX localization. When a PTX is spotted, the overlay is shown in the area where the PTX was located to improve diagnostic speed and accuracy, GE HealthCare said.
“Artificial intelligence applications in healthcare continue to prove their value in clinical practice and on the frontlines of patient care,” Jyoti Gupta Ph.D., president and CEO of Women’s Health and X-ray for GE HealthCare, told the press. “The adoption of these digital solutions helps unlock efficiencies across the entire clinical workflow and empowers radiologists and their teams in making critical decisions with confidence in time-sensitive situations. We are excited by the paradigm shift this kind of innovation can bring in the delivery of timely and efficient patient care enabling enhanced clinical outcomes when it matters most.”
The company claims the PTX algorithm partially localizes 100% of all detected large PTXs and 96% of all detected small PTXs, and limits false alerts (94% specificity). Results from other clinical studies also showed 57% reduction in reporting times for clinical, actionable PTXs and 17.7% increase in clinician detection of small PTXs.
“The ultimate journey for an AI tool from bench to bedside is when you involve the entire clinical team including bedside Physicians, Nurse Practitioners and Radiologists,” said Dr Amit Gupta, division chief of cardiothoracic imaging, University Hospitals of Cleveland. “GE HealthCare’s innovation with Critical Care Suite to have alerts on mobile systems is helping clinicians make decisions with confidence in these critical moments.”
GE HealthCare’s Critical Care Suite was co-developed with UCSF's Center for Digital Health Innovation (CDHI) and the company said its AMX platform is the first mobile X-ray system to offer this on-device embedded artificial intelligence for triage.
The updated PTX algorithm offers immediate notification of presence or absence of pneumothorax, as well as an overlay display both on the device and in PACS to help with PTX localization. When a PTX is spotted, the overlay is shown in the area where the PTX was located to improve diagnostic speed and accuracy, GE HealthCare said.
“Artificial intelligence applications in healthcare continue to prove their value in clinical practice and on the frontlines of patient care,” Jyoti Gupta Ph.D., president and CEO of Women’s Health and X-ray for GE HealthCare, told the press. “The adoption of these digital solutions helps unlock efficiencies across the entire clinical workflow and empowers radiologists and their teams in making critical decisions with confidence in time-sensitive situations. We are excited by the paradigm shift this kind of innovation can bring in the delivery of timely and efficient patient care enabling enhanced clinical outcomes when it matters most.”
The company claims the PTX algorithm partially localizes 100% of all detected large PTXs and 96% of all detected small PTXs, and limits false alerts (94% specificity). Results from other clinical studies also showed 57% reduction in reporting times for clinical, actionable PTXs and 17.7% increase in clinician detection of small PTXs.
“The ultimate journey for an AI tool from bench to bedside is when you involve the entire clinical team including bedside Physicians, Nurse Practitioners and Radiologists,” said Dr Amit Gupta, division chief of cardiothoracic imaging, University Hospitals of Cleveland. “GE HealthCare’s innovation with Critical Care Suite to have alerts on mobile systems is helping clinicians make decisions with confidence in these critical moments.”
GE HealthCare’s Critical Care Suite was co-developed with UCSF's Center for Digital Health Innovation (CDHI) and the company said its AMX platform is the first mobile X-ray system to offer this on-device embedded artificial intelligence for triage.